RankingsPricing
  1. US-listed companies
  2. ABEONA THERAPEUTICS INC.
  3. Financials
  4. Revenue

ABEONA THERAPEUTICS INC.ABEO

Market cap
$248.11M
P/E ratio
SummaryFinancials
Period EndRevenue (Million USD)YoY (%)
Dec 31, 20234+147.52%
Dec 31, 20221-52.87%
Dec 31, 20213-70.00%
Dec 31, 202010+233.56%
Dec 31, 20183+258.18%
Dec 31, 20171-5.85%
Dec 31, 20161-14.52%
Dec 31, 20151+12.43%
Dec 31, 20141-54.70%
Dec 31, 20132-53.63%
Dec 31, 20124+138.31%
Dec 31, 20112

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)